Abstract
BackgroundFluoropyrimidines (FPs) form still nowadays the backbone of chemotherapic schemes in colorectal cancer (CRC). Inter-patient variability of t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
